share_log

Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $62 Price Target

Benzinga ·  Sep 16 11:44

Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment